Catalyst Wire Dossier Catalyst Wire Dossier

oréVida

· dsm-firmenich Switzerland AG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for oréVida, covering 2011-06-09 to 2011-06-09. Get the full timeline:

Most recent: Clinical Trial Update: A Randomized, Placebo-Controlled, Double-Blind, Crossover Study to Evaluate the Effects of Three Doses of the Dietary Supplement oréVida™ on Alertness, Attention and Concentration in Healthy Men and Women [Phase 1]

See pricing